发明名称 |
Composition and method for treatment of diabetes |
摘要 |
The present invention relates to a method of treating an incretin related disease such as diabetes, obesity and the like by delivery of butyric acid, bile acid, long chain fatty acid or glutamine to the colon by bypassing the upper digestive tract. The composition is combined either by the same or different route of administration with a monoamine reuptake inhibitor such as buproprion. |
申请公布号 |
US9301938(B2) |
申请公布日期 |
2016.04.05 |
申请号 |
US201013497114 |
申请日期 |
2010.09.22 |
申请人 |
BioKier, Inc. |
发明人 |
Szewczyk Jerzy Ryszard |
分类号 |
A61K31/198;A61K31/137;A61K45/06;A61K31/185;A61K9/00;A61K9/20;A61K31/537 |
主分类号 |
A61K31/198 |
代理机构 |
Passé Intellectual Property, LLC |
代理人 |
Passé James G.;Passé Intellectual Property, LLC |
主权项 |
1. A method of treating type II diabetes in an individual consisting of:
a) selecting glutamine formulated to release in an oral colon targeted delivery system; b) orally administering sufficient formulated glutamine to the individual via a colon targeted delivery system sufficient to treat type II diabetes, wherein the amount of glutamine administered is in the range of 0.3 to 30 mg/kg body weight per day; and c) orally administering an amount of a monoamine reuptake inhibitor to the individual sufficient to ameliorate an increase in compulsive behavior caused by step b. |
地址 |
Chapel Hill NC US |